vs

Side-by-side financial comparison of Ballard Power Systems Inc. (BLDP) and Community Healthcare Trust Inc (CHCT). Click either name above to swap in a different company.

Community Healthcare Trust Inc is the larger business by last-quarter revenue ($30.9M vs $17.7M, roughly 1.7× Ballard Power Systems Inc.). Ballard Power Systems Inc. runs the higher net margin — 994.4% vs 46.6%, a 947.8% gap on every dollar of revenue.

Ballard Power Systems Inc. is a developer and manufacturer of proton exchange membrane (PEM) fuel cell products for markets such as heavy-duty motive, portable power, material handling as well as engineering services. Ballard has designed and shipped over 400 MW of fuel cell products to date.

Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...

BLDP vs CHCT — Head-to-Head

Bigger by revenue
CHCT
CHCT
1.7× larger
CHCT
$30.9M
$17.7M
BLDP
Higher net margin
BLDP
BLDP
947.8% more per $
BLDP
994.4%
46.6%
CHCT

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
BLDP
BLDP
CHCT
CHCT
Revenue
$17.7M
$30.9M
Net Profit
$176.5M
$14.4M
Gross Margin
Operating Margin
Net Margin
994.4%
46.6%
Revenue YoY
5.6%
Net Profit YoY
687.6%
EPS (diluted)
$0.52

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BLDP
BLDP
CHCT
CHCT
Q4 25
$30.9M
Q3 25
$17.7M
$31.1M
Q2 25
$29.1M
Q1 25
$30.1M
Q4 24
$29.3M
Q3 24
$-12.3M
$29.6M
Q2 24
$27.5M
Q1 24
$29.3M
Net Profit
BLDP
BLDP
CHCT
CHCT
Q4 25
$14.4M
Q3 25
$176.5M
$1.6M
Q2 25
$-12.6M
Q1 25
$1.6M
Q4 24
$1.8M
Q3 24
$1.7M
Q2 24
$-10.4M
Q1 24
$3.7M
Gross Margin
BLDP
BLDP
CHCT
CHCT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
156.5%
Q2 24
Q1 24
Net Margin
BLDP
BLDP
CHCT
CHCT
Q4 25
46.6%
Q3 25
994.4%
5.3%
Q2 25
-43.2%
Q1 25
5.3%
Q4 24
6.3%
Q3 24
5.9%
Q2 24
-37.9%
Q1 24
12.5%
EPS (diluted)
BLDP
BLDP
CHCT
CHCT
Q4 25
$0.52
Q3 25
$0.03
Q2 25
$-0.50
Q1 25
$0.03
Q4 24
$0.04
Q3 24
$0.04
Q2 24
$-0.42
Q1 24
$0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BLDP
BLDP
CHCT
CHCT
Cash + ST InvestmentsLiquidity on hand
$3.3M
Total DebtLower is stronger
$532.2M
Stockholders' EquityBook value
$429.4M
Total Assets
$990.8M
Debt / EquityLower = less leverage
1.24×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BLDP
BLDP
CHCT
CHCT
Q4 25
$3.3M
Q3 25
$3.4M
Q2 25
$4.9M
Q1 25
$2.3M
Q4 24
$4.4M
Q3 24
$2.8M
Q2 24
$734.0K
Q1 24
$3.8M
Total Debt
BLDP
BLDP
CHCT
CHCT
Q4 25
$532.2M
Q3 25
$530.1M
Q2 25
$500.1M
Q1 25
$496.0M
Q4 24
$486.0M
Q3 24
$473.7M
Q2 24
$457.6M
Q1 24
$442.3M
Stockholders' Equity
BLDP
BLDP
CHCT
CHCT
Q4 25
$429.4M
Q3 25
$426.8M
Q2 25
$437.8M
Q1 25
$461.3M
Q4 24
$476.0M
Q3 24
$477.2M
Q2 24
$497.8M
Q1 24
$511.6M
Total Assets
BLDP
BLDP
CHCT
CHCT
Q4 25
$990.8M
Q3 25
$987.3M
Q2 25
$966.3M
Q1 25
$985.1M
Q4 24
$992.6M
Q3 24
$981.8M
Q2 24
$983.2M
Q1 24
$982.7M
Debt / Equity
BLDP
BLDP
CHCT
CHCT
Q4 25
1.24×
Q3 25
1.24×
Q2 25
1.14×
Q1 25
1.08×
Q4 24
1.02×
Q3 24
0.99×
Q2 24
0.92×
Q1 24
0.86×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BLDP
BLDP
CHCT
CHCT
Operating Cash FlowLast quarter
$5.7M
$56.4M
Free Cash FlowOCF − Capex
$35.9M
FCF MarginFCF / Revenue
116.0%
Capex IntensityCapex / Revenue
66.3%
Cash ConversionOCF / Net Profit
0.03×
3.91×
TTM Free Cash FlowTrailing 4 quarters
$62.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BLDP
BLDP
CHCT
CHCT
Q4 25
$56.4M
Q3 25
$5.7M
$12.7M
Q2 25
$13.8M
Q1 25
$14.4M
Q4 24
$58.9M
Q3 24
$-6.6M
$13.8M
Q2 24
$16.7M
Q1 24
$12.6M
Free Cash Flow
BLDP
BLDP
CHCT
CHCT
Q4 25
$35.9M
Q3 25
$7.6M
Q2 25
$9.6M
Q1 25
$9.7M
Q4 24
$34.2M
Q3 24
$6.7M
Q2 24
$9.5M
Q1 24
$7.5M
FCF Margin
BLDP
BLDP
CHCT
CHCT
Q4 25
116.0%
Q3 25
24.6%
Q2 25
32.9%
Q1 25
32.3%
Q4 24
116.9%
Q3 24
22.5%
Q2 24
34.7%
Q1 24
25.7%
Capex Intensity
BLDP
BLDP
CHCT
CHCT
Q4 25
66.3%
Q3 25
16.3%
Q2 25
14.5%
Q1 25
15.6%
Q4 24
84.1%
Q3 24
24.2%
Q2 24
26.1%
Q1 24
17.4%
Cash Conversion
BLDP
BLDP
CHCT
CHCT
Q4 25
3.91×
Q3 25
0.03×
7.76×
Q2 25
Q1 25
9.06×
Q4 24
32.14×
Q3 24
7.92×
Q2 24
Q1 24
3.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons